EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing. - Wikidata - wikimedia - TriplyDB

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

http://www.wikidata.org/entity/Q34016908

about

Estrogen receptor alpha gene amplification in breast cancer: 25 years of debate Single-cell analysis tools for drug discovery and development Intra-tumor heterogeneity of cancer cells and its implications for cancer treatment Advances and applications of single-cell sequencing technologies Heterogeneity of epidermal growth factor receptor signalling networks in glioblastoma Chromothripsis from DNA damage in micronuclei.Single-cell sequencing and tumorigenesis: improved understanding of tumor evolution and metastasis.NGSCheckMate: software for validating sample identity in next-generation sequencing studies within and across data types.Greater than the sum of its parts: single-nucleus sequencing identifies convergent evolution of independent EGFR mutants in GBM.Identification of focally amplified lineage-specific super-enhancers in human epithelial cancers.A urokinase receptor-Bim signaling axis emerges during EGFR inhibitor resistance in mutant EGFR glioblastoma.Whole-genome and multisector exome sequencing of primary and post-treatment glioblastoma reveals patterns of tumor evolution Optimizing sparse sequencing of single cells for highly multiplex copy number profiling Calibrating genomic and allelic coverage bias in single-cell sequencing.Soluble Urokinase Receptor Is Released Selectively by Glioblastoma Cells That Express Epidermal Growth Factor Receptor Variant III and Promotes Tumor Cell Migration and Invasion.FoxM1 Promotes Stemness and Radio-Resistance of Glioblastoma by Regulating the Master Stem Cell Regulator Sox2.Proteomic profiling of patient-derived glioblastoma xenografts identifies a subset with activated EGFR: implications for drug development.A wide spectrum of EGFR mutations in glioblastoma is detected by a single clinical oncology targeted next-generation sequencing panel Clinical implementation of integrated whole-genome copy number and mutation profiling for glioblastoma.Single-cell sequencing maps gene expression to mutational phylogenies in PDGF- and EGF-driven gliomas Genetic Testing and Tissue Banking for Personalized Oncology: Analytical and Institutional Factors.CD151-α3β1 integrin complexes are prognostic markers of glioblastoma and cooperate with EGFR to drive tumor cell motility and invasion.Structure and mechanism of activity-based inhibition of the EGF receptor by Mig6 Rapid Intraoperative Molecular Characterization of Glioma.Cell line with endogenous EGFRvIII expression is a suitable model for research and drug development purposes.Advances in Immunotherapy for Glioblastoma Multiforme.Mapping heterogeneity in patient-derived melanoma cultures by single-cell RNA-seq.Molecular pathologic diagnosis of epidermal growth factor receptor.Advances and challenges in the molecular biology and treatment of glioblastoma-is there any hope for the future?Chromosomal Instability and Phosphoinositide Pathway Gene Signatures in Glioblastoma Multiforme ReACT Phase II trial: a critical evaluation of the use of rindopepimut plus bevacizumab to treat EGFRvIII-positive recurrent glioblastoma.Molecular profiling of gliomas: potential therapeutic implications.Emerging circulating biomarkers in glioblastoma: promises and challenges.Glioblastoma targeted therapy: updated approaches from recent biological insights.Implications of mitogen-activated protein kinase signaling in glioma.New library construction method for single-cell genomes.Antibody-drug conjugates in glioblastoma therapy: the right drugs to the right cells.EGFRvIII mutations can emerge as late and heterogenous events in glioblastoma development and promote angiogenesis through Src activation.From Mutational Mechanisms in Single Cells to Mutational Patterns in Cancer Genomes.Genetic biomarkers of drug response for small-molecule therapeutics targeting the RTK/Ras/PI3K, p53 or Rb pathway in glioblastoma.

P2860

Q24273274-D1F2D311-1CD7-4A4D-84A9-30F54399FF22 Q26775754-B26ADA67-1E72-4180-88A9-755466DF0A15 Q26783055-2FAF9945-0072-43F0-ABF5-53BFA3406783 Q27004390-E4A38BEE-65CC-497B-9A66-9AD8702433B7 Q27013006-46AC92FC-4371-47B2-B8EB-452FD4766297 Q27316519-074B2E4F-1B62-4D05-BAC6-5BF7265B5971 Q33559128-C0394445-3B89-4221-B1B8-79C67053BCFD Q33878427-802768B6-FA85-464D-8C54-1197B9ACA3C0 Q33923431-AD03DD1E-FADA-4C66-B203-97CA902AB1AF Q34504751-4F539431-8CF0-4A54-829B-CFE475ED1B84 Q34979703-68B5CBEE-0B0F-4D5C-A99C-12F591D8856C Q35157212-E5C7CBC7-0644-4CF6-8AD1-6E516C2D2589 Q35561968-E78C285A-2266-4F5C-BE7E-FACBBFCE5D23 Q35603470-9B6C4B9E-D7D6-4656-9D2E-262C81EC235E Q35721585-ED044605-7D46-4A38-9B08-EC1644058CC4 Q35800767-BF119682-DC1C-41C2-9009-0E37626664D9 Q35887828-FB8A4D9F-F714-4E43-9561-2A46133DFF04 Q35963284-51481C03-4C23-4EDC-AD88-4949222834E4 Q36082467-75E4D63C-7C31-45A1-BFAD-87A9B530B689 Q36204396-8EBF481B-C43D-4A60-A0E5-4F407104994D Q36441399-9A88272E-74C5-4DA7-B8CE-3550FCB8D407 Q36557409-8D7EFEC6-A8A1-45E1-A5AA-AA12DF522623 Q36683851-9E28AA4D-1A61-482E-BD9B-0B45A5F8D8CD Q36914510-F9C75374-E7CD-4CDA-8DB8-ACBCC30747ED Q37362563-79A7F97F-94D4-4A4D-87DC-DE61146C8190 Q37680966-A55DE3D1-AC78-4713-91AF-EBFC32B5683B Q37702372-849CB40B-E43A-4216-B429-8D7BBE7A7540 Q38262472-DDD977E5-8709-480D-BC26-F4C3E446E25B Q38364234-C9E9EBDE-41BF-427A-87A5-79CFE3315020 Q38388784-5FCAD347-2110-4593-8B08-613B54D7E5B1 Q38398440-2ADFB231-6628-40CB-8F32-07E6C8EC4433 Q38539422-2BD38DF3-A4BB-4D44-8460-F71A2818EFDF Q38591062-017B6C82-FD49-431B-A51A-A6ABFF3AEF97 Q38597700-6BF0370D-D575-49C6-9451-2A3A18EA42E3 Q38618205-1738FCAF-94A7-4830-83C6-620650C3D91F Q38671876-A02FD85E-0F22-4347-A258-A1039A90DB74 Q38694765-AAECEDE8-9629-4B84-8374-31D9F264B555 Q38765219-B9615ADB-6187-4ED2-85E7-6D2E76132370 Q38770485-185B53DE-AD57-4902-ADED-5E50511E5779 Q38778367-CEE25CCE-A17F-4154-BE93-81A085A7F2F0

P2860

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

http://www.wikidata.org/entity/Q34016908

description

2014 nî lūn-bûn

@nan

2014 թուականի Յունիսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի հունիսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@ast

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@en

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@nl

type

label

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@ast

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@en

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@nl

prefLabel

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@ast

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@en

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@nl

P1433

Q34016908-5051802E-C6CC-416F-8A20-D86CBDF1C2B6

P1476

Q34016908-8F75C35B-732D-44A4-A551-8B069AE67354

P2093

Q34016908-17532805-28D7-4E6E-98F6-B714C6A9652A

Q34016908-2A0B624D-BF03-4476-8C92-A828C4F2AE0D

Q34016908-30BA00DD-D7B8-4B08-BBF5-189DC928EB89

Q34016908-58FEB1F0-7111-4D9C-8435-EC6687F8A20D

Q34016908-71E02ED7-F4DE-4FE7-8585-9BD72F77FA15

Q34016908-85BAC2E4-31EC-4BEA-8051-7B3F3C11D7A7

Q34016908-98C20B4C-8522-4E40-AE3B-B76A96334730

Q34016908-A0324641-049B-4EC3-813C-30A7BC683099

Q34016908-C9052A65-5E3D-4E05-8811-09B266ED89B8

Q34016908-CEAE6683-6798-4C73-9231-29D9AD864D8C

P2860

Q34016908-07022A49-C9EA-4678-982C-E200B0232199

Q34016908-0AA1571B-0AD0-4CFC-B6C8-6FFC3F9B43D4

Q34016908-0D2E743D-E9D5-4139-9E34-1938EBC7F592

Q34016908-111AFD95-7016-44FC-8930-3C0BFF13B70F

Q34016908-14218EE1-4C61-4DC4-B08C-E1F6EB39F478

Q34016908-150A9957-A0ED-4B1E-B50C-4C2D1ED422AE

Q34016908-1C922F1E-AD6B-4071-B9D0-390A48FD0614

Q34016908-1E4BDE03-8A53-4F05-B20F-96C4920DAE65

Q34016908-1E74D7C8-AB3C-4092-B1FE-9B476918E300

Q34016908-1EA8D15F-4C9D-4873-8402-E1EF3BB44176

P304

Q34016908-FD9AA92A-DB11-4CFE-ADCA-4506164F46B2

P31

Q34016908-8DBADF10-2236-4FBC-94A6-F963BCDA4D4F

P356

Q34016908-324F374F-83EB-4EA8-BE7A-4C26ECD41A51

P433

Q34016908-5DD975E4-4E7D-4500-B18D-18A13E13D132

P478

Q34016908-59B92575-E70B-45F0-8B3C-226249ABF1A9

P50

Q34016908-7E76DC0A-C049-4817-AEE7-92F8D206140E

Q34016908-9B54E74B-DAB0-4392-BC54-61FC05AA0CDB

P577

Q34016908-829D85B5-AA30-4024-AB3E-2392F0B746EE

P698

Q34016908-030B8791-A6A2-4703-9AAF-BAC957C1BA01

P932

Q34016908-9F7B604A-A193-4C2C-B30E-3C302CCB3F36

P356

2159-8290.CD-13-0879

P1433

Cancer Discovery

P1476

EGFR variant heterogeneity in glioblastoma resolved through single-nucleus sequencing.

@en

P2093

Azra H Ligon

http://www.w3.org/2001/XMLSchema#string

Brendan Blumenstiel

http://www.w3.org/2001/XMLSchema#string

Cecile L Maire

http://www.w3.org/2001/XMLSchema#string

Cheng-Zhong Zhang

http://www.w3.org/2001/XMLSchema#string

Heather Homer

http://www.w3.org/2001/XMLSchema#string

J Christopher Love

http://www.w3.org/2001/XMLSchema#string

Joonil Jung

http://www.w3.org/2001/XMLSchema#string

Joshua M Francis

http://www.w3.org/2001/XMLSchema#string

Keith L Ligon

http://www.w3.org/2001/XMLSchema#string

Sam Haidar

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer genome landscapes

EGFR phosphorylates tumor-derived EGFRvIII driving STAT3/5 and progression in glioblastoma

Genome-wide detection of single-nucleotide and copy-number variations of a single human cell

An integrated genomic analysis of human glioblastoma multiforme

Integrated genomic analysis identifies clinically relevant subtypes of glioblastoma characterized by abnormalities in PDGFRA, IDH1, EGFR, and NF1

Comprehensive genomic characterization defines human glioblastoma genes and core pathways

Evolution of the cancer genome

EGFR mutation and resistance of non-small-cell lung cancer to gefitinib.

Intratumor Heterogeneity and Branched Evolution Revealed by Multiregion Sequencing

Epidermal growth factor receptor activation in glioblastoma through novel missense mutations in the extracellular domain

P304

956-971

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1158/2159-8290.CD-13-0879

http://www.w3.org/2001/XMLSchema#string

P433

8

http://www.w3.org/2001/XMLSchema#string

P478

4

http://www.w3.org/2001/XMLSchema#string

P50

Chandra Sekhar Pedamallu

Matthew Meyerson

P577

2014-06-03T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

24893890

http://www.w3.org/2001/XMLSchema#string

P932

4125473

http://www.w3.org/2001/XMLSchema#string